Research Affiliates

Institute for Cancer Genetics (ICG)

The Institute for Cancer Genetics was founded in 1999 as part of a commitment by Columbia University to examine the molecular mechanisms and pathogenesis of cancer. Researchers within the Institute use traditional approaches such as transgenic mice to model human cancers and also take advantage of new technology such as DNA Chip microarrays to identify and characterize key proteins involved in the process of tumor initiation and progression.

The Taub Institute

The Taub Institute for Research on Alzheimer's Disease and the Aging Brain is the nucleus of a dynamic, multidisciplinary endeavor. The institute brings together Columbia university researchers and clinicians to uncover the causes of Alzheimer’s, Parkinson’s and other age-related brain diseases and discover ways to prevent and cure these diseases.

Stem Cell Center

The Columbia University Stem Cell Consortium is a community of researchers from a variety of medical and scientific disciplines. Their investigative efforts strive to translate basic science studies into clinical treatments that will defeat the advancement of many chronic and untreatable diseases.

The Stem Cell Consortium is deeply committed to the conversion of stem cells into a source of future cell-based therapies. Our researchers continue to examine both adult and embryonic stem cells to study the normal birth, maturation and death of cells; to repair or replace cells or tissues that are damaged or destroyed by many of our most devastating diseases and disabilities, such as ALS, Parkinson's, juvenile diabetes, as well as brain injury stroke; to employ stem cells from humans and animal models to study mechanisms of human diseases; and as a tool to develop new drug therapies.

Columbia University Medical Center researchers, using mouse embryonic stem cells and following the nerve cell’s own developmental recipe, have produced and isolated motor neurons that make appropriate connections to muscle during development. Besides its impact on ALS research, the Columbia protocol can be applied to create better stem cell-derived cells for research into therapies for other neurodegenerative disorders, such as Parkinson’s disease. Columbia researchers have also shown recently that adult stem cells from the bone marrow can help regenerate lost blood vessels and heart cells after heart attacks in rats. The Stem Cell Consortium continues to expand its research efforts through collaboration and education.

The Columbia University Center for AIDS Research

The Columbia University Center for AIDS Research (CU-CFAR) is a center funded by the National Institutes of Health (NIH), and is designed to stimulate collaborations and interdisciplinary research among a diverse group of investigators including: basic, clinical, epidemiological, behavioral, and translational researchers dedicated to prevention, detection, and treatment of HIV/AIDS.

The Motor Neuron Center

Columbia’s Motor Neuron Center will transform out understanding of human health. For the first time, brilliant scientific minds are working together in a common approach to currently incurable motor neuron diseases: spinal muscular atrophy (SMA) in children and amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease) in adults. New discoveries in the field of motor neuron biology will fuel the search for effective therapy for patients.

Hospital Affiliates

Helen Hayes Hospital

New York Presbyterian Hospital

Lawrence Hospital



Steve Russo, MPA
Research Administrator

P: 212 305-1513
F: 212 342-3013

Frances Antonetty

Irene D'Silva

Josie Salcedo

Contact Numbers

Phone: 212 305-7166 (x5-7166)
Phone: 212 305-3451 (x5-3451)
Fax: 212 342-3013

Mailing Address:

Columbia University
Department of Pathology & Cell Biology
630 W. 168th Street
Box #23
New York, NY 10032
Contact the Pathology Webmaster at